CVRx (Series B, Series F, Action Potential)

Funding Details
Awarder
Inbox
Date Award
May 20, 2025
Vertical
Medical Devices
Funding URL
View Funding Page
Funding Amount:
$154,600,000
Company Info
Founding Year
2001
Traction
CVRx has treated more than 625 patients with its patented devices.
Company Description
CVRx, Inc. is a privately held company founded in 2001 and headquartered in Minneapolis. The company has developed the Barostim neo™, an implantable system designed to treat hypertension and heart failure.
Market
Hypertension and Heart Failure Treatment
Location
Minneapolis, Minnesota, United States
Coinvestors
BBT Fund, Johnson & Johnson Innovation, SightLine Partners, DaVita HealthCare Partners, Ysios Capital, Action Potential Venture Capital, Gilde Healthcare Partners, Oxford Finance, Windham Venture Partners, Ysios BioFund
Links
Back to Home Back to Medical Devices Deals View Funding Announcement